|
论感染性休克治疗进展 |
| |
bsp;Berghe G,Wouters PJ，Bouillon R，et a1.Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.Crit Care Med,2003,31(2): 359366
22Van den Berghe G,Wilmer A，Hermans G,et al.Intensive insulin therapy in the medical ICU.N Engl J Med,2006,354(5): 449461
23邱海波.严重感染和感染性休克的治疗进展.中华肝胆外科杂志,2007,13(1): 46
24Bernard GR,Vincent JL,Laterre PF,et a1.Efficacy and safety of recombinant human activated protein C for severe sepsis.N End J Med,2001,344(10): 699709
25Bernard GR,Macias WL,Joyce DE,et a1.Safety assessment of drotrecogin alfa (activated ) in the treatment of adult patients with severe sepsis.Crit Care,2003,7(2): 155163
26Pinsky MR，Vincent JL，Devier J et al.Serum cytokine levels in human septic shock.Relation to multiplesystem organ failure and mortality.Chest,1993,103(2): 565575
27De Vriese AS,Vanholder RC,Pascual M,et al.Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies? Intensive Care Med，1999,25(9): 903910
28Cole L,Bellomo R,Journois D,et a1.Highvolume haemofiltration in human septic shock.Intensive Care Med,2001,27(6): 978986
29Doerschug KC,Powers LS,Monick MM,et al.Antibiotics delay but do not prevent bactere上一页 [1] [2] [3] [4] [5] [6] [7] 下一页
上一个医学论文： 浅论解脲支原体感染致男性不育症研究进展
下一个医学论文： 论慢性阻塞性肺疾病气道重构研究进展
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 中医论文 >> 正文